Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06815536 · ClinicalTrials.gov registry record
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
A clinical trial of Neisseria Gonorrheae Infection, sponsored by Duke University.
- Recruiting
- Registry status
- 3,291
- Enrollment target
- 8
- Study locations
NCT06815536 is a study of Neisseria Gonorrheae Infection that is actively recruiting participants, run by Duke University. The registered enrollment target is 3,291 participants. The trial reports 8 study locations across 8 states.
The verdict
NCT06815536, a study of Neisseria Gonorrheae Infection, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 3,291 participants
- Enrollment target
- 8
- Study locations
Study Summary
The goal of this study is to learn if a few investigational tests can correctly find the gene mutation (mutant allele gyrA 91F) that predicts ciprofloxacin resistance in clinical specimens that harbor Neisseria gonorrhoeae. The main question the study aims to answer: Can the investigational reflex test find the correct gene mutation (Neisseria gonorrhoeae gyrA 91F or gyrA 91S) as compared to the sequenced result? Specimens that are collected for routine clinical care and harbor Neisseria gonorrhoeae will be evaluated in this study.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Investigational Reflex Test 1
- DIAGNOSTIC_TEST Investigational Reflex Test 2
- DIAGNOSTIC_TEST Investigational Reflex Test 3
Study Locations (8)
California
- San Francisco Public Health Laboratory - San Francisco
Indiana
- Indiana University School of Medicine - Indianapolis
Mississippi
- Mississippi State Department of Public Health - Jackson
Missouri
- Corewell Health - Royal Oak
North Carolina
- LabCorp - Durham
Utah
- ARUP Laboratories - Salt Lake City
Virginia
- University of Virginia School of Medicine - Charlottesville
Washington
- Molecular Testing Labs - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,291 participants |
| Start Date | 2025-04-16 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06815536
The ClinicalTrials.gov registry entry for NCT06815536 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neisseria Gonorrheae Infection appearing as the primary indexed condition, and to 3 interventions - of which Investigational Reflex Test 1 is the first listed.
NCT06815536 reports 8 study locations spanning 8 distinct geographic areas - top geographies include California, Indiana, Mississippi.
Frequently Asked Questions
What is clinical trial NCT06815536 about?
NCT06815536 is a clinical study titled "Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae". The goal of this study is to learn if a few investigational tests can correctly find the gene mutation (mutant allele gyrA 91F) that predicts ciprofloxacin resistance in clinical specimens that harbor Neisseria gonorrhoeae. The main question the study aims to answer: Can the investigational reflex ...
What is the current status of trial NCT06815536?
This trial is currently recruiting. The enrollment target is 3,291 participants. The study started on 2025-04-16. Estimated completion is 2026-07.
What conditions does trial NCT06815536 study?
This clinical trial studies the following conditions: Neisseria Gonorrheae Infection.
What interventions are being tested in trial NCT06815536?
The interventions under investigation include: Investigational Reflex Test 1 (DIAGNOSTIC_TEST), Investigational Reflex Test 2 (DIAGNOSTIC_TEST), Investigational Reflex Test 3 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06815536?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06815536 being conducted?
This trial has 8 study locations across California, Indiana, Mississippi, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neisseria Gonorrheae Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.